Evidence map›Paper›PMID 34258163›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2021

The m6A Reader IGF2BP2 Regulates Macrophage Phenotypic Activation and Inflammatory Diseases by Stabilizing TSC1 and PPAR

Xia Wang, Yuge Ji, Panpan Feng, Rucheng Liu, Guosheng Li, Junjie Zheng, Yaqiang Xue, Yaxun Wei, Chunyan Ji, Dawei Chen and 1 more

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 107 papers.

0numbers the graph read from it
0cells of the map it votes in
107citing papers in PubMed
8.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

107 citing papers in PubMed, 141 citations in OpenAlex.

  1. Article
  2. Article
  3. Chiral FeBioactive materials · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Deficiency of the mCellular and molecular life sciences : CMLS · 2026
    Article
  8. mInternational journal of molecular medicine · 2026
    Review
  9. Article
  10. Targeting intracellular mRNA mJournal of advanced research · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. mFrontiers in immunology · 2026
    Article
  19. Review
  20. mFrontiers in immunology · 2026
    Review

47 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Xia WangDepartment of Physiology School of Basic Medical Sciences Cheeloo College of Medicine Shandong University Jinan Shandong 250012 China.
Yuge JiDepartment of Physiology School of Basic Medical Sciences Cheeloo College of Medicine Shandong University Jinan Shandong 250012 China.
Panpan FengDepartment of Hematology Qilu Hospital Cheeloo College of Medicine Shandong University Jinan Shandong 250012 China.
Rucheng LiuDepartment of Physiology School of Basic Medical Sciences Cheeloo College of Medicine Shandong University Jinan Shandong 250012 China.
Guosheng LiDepartment of Hematology Qilu Hospital Cheeloo College of Medicine Shandong University Jinan Shandong 250012 China.
Junjie ZhengDepartment of Physiology School of Basic Medical Sciences Cheeloo College of Medicine Shandong University Jinan Shandong 250012 China.
Yaqiang XueABLife BioBigData Institute Wuhan Hubei 430075 China.
Yaxun WeiCenter for Genoem Analysis ABLife Inc. Wuhan Hubei 430075 China.
Chunyan JiDepartment of Hematology Qilu Hospital Cheeloo College of Medicine Shandong University Jinan Shandong 250012 China.
Dawei ChenLaboratory of Medical Chemistry Interdisciplinary Cluster for Applied Genoproteomics (GIGA) Stem Cells University of Liège CHU, Sart-Tilman Liège 4000 Belgium.ORCID 0000-0002-2541-4512
Jingxin LiDepartment of Physiology School of Basic Medical Sciences Cheeloo College of Medicine Shandong University Jinan Shandong 250012 China.
Shandong University · CNQilu Hospital of Shandong University · CNUniversity of Liège · BEWuhan Institute of Bioengineering · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phenotypic polarization of macrophages is regulated by a milieu of cues in the local tissue microenvironment. Currently, little is known about how the intrinsic regulators modulate proinflammatory (M1) versus prohealing (M2) macrophages activation. Here, it is observed that insulin-like growth factor 2 messenger RNA (mRNA)-binding protein 2 (IGF2BP2)-deleted macrophages exhibit enhanced M1 phenotype and promote dextran sulfate sodium induced colitis development. However, the IGF2BP2

Indexed as

AnimalsCell DifferentiationDisease Models, AnimalFemaleInflammationMacrophage ActivationMaleMiceMice, Inbred C57BLPhenotypePPAR gammaRNA-Binding ProteinsSignal TransductionTuberous Sclerosis Complex 1 ProteinIGF2BP2 protein, mousePPAR gammaRNA-Binding ProteinsTsc1 protein, mouseTuberous Sclerosis Complex 1 ProteinIGF2BP2inflammatory diseasesm6A readermacrophage polarizationTSC1

Identifiers

PMID34258163
PMCPMC8261491
OpenAlexW3159609918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.